Royal Bank Of Canada Epizyme, Inc. Transaction History

Royal Bank Of Canada

  • $425 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.42 - $1.48 $3,698 - $13,031
-8,805 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.06 - $2.68 $12,721 - $32,162
-12,001 Reduced 57.68%
8,805 $10,000
Q4 2021

Feb 14, 2022
BUY
$2.5 - $5.19 $25,940 - $53,851
10,376 Added 99.48%
20,806 $52,000
Q3 2021

Nov 15, 2021
BUY
$4.82 - $8.46 $20,644 - $36,234
4,283 Added 69.68%
10,430 $53,000
Q2 2021

Aug 16, 2021
BUY
$6.81 - $9.71 $41,861 - $59,687
6,147 New
6,147 $51,000

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email